Author(s): Shen Jinwen, Zhu Yuan
Pages: 578-581
Year: 2017 Issue:  5
Journal: Chinese Journal of Radiation Oncology
Keyword:  Hodgkin disease/radiotherapy; Hodgkin disease/chemotherapy; Risk assessment; Tomography; positron-emission;
Abstract: Much progress has been made in the diagnosis and treatment of Hodgkin's lymphoma, which has become a highly curable malignancy.However, prolonged survival makes clinicians pay more attention to long-term toxicities of treatment.Consequently, individualized treatment based on disease stage and risk factors is a research hotspot at present.This article reviews recent advances in the individualized treatment of early-stage classical Hodgkin's lymphoma.